Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
Division of General Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
Colorectal Dis. 2023 Jul;25(7):1336-1348. doi: 10.1111/codi.16571. Epub 2023 Apr 8.
Young women undergoing radiotherapy (RT) for pelvic malignancies are at risk of developing premature ovarian insufficiency. Ovarian transposition (OT) aims to preserve ovarian function in these patients. However, its role in anorectal malignancy has yet to be firmly established. The aim of this review was to determine the effectiveness of laparoscopic OT in preserving ovarian function in premenopausal women undergoing neoadjuvant pelvic RT for anorectal malignancies.
MEDLINE, Embase and CENTRAL were systematically searched from inception through to May 2022. Articles were included if they evaluated ovarian function after OT in women with anorectal malignancies undergoing pelvic RT. The primary outcome was ovarian function preservation. The secondary outcome was 30-day postoperative morbidity following OT.
From 207 citations, 10 studies with 133 patients with rectal or anal cancer who underwent OT prior to RT were included. Meta-analysis of pooled proportions of preserved ovarian function demonstrated an incidence of 66.9% (95% CI 55.0-79.0%, I = 43%). The 30-day postoperative morbidity rate was 1.2% (n = 1). There was heterogeneity in interventions and outcome reporting.
Laparoscopic OT in premenopausal patients undergoing pelvic radiation for anorectal malignancies might be an effective technique at reducing ovarian exposure to RT. The meta-analyses must be interpreted within the context of clinical heterogeneity of the included studies. Further studies are required to fully investigate the outcomes of OT in patients undergoing pelvic radiation for anorectal malignancies.
接受盆腔恶性肿瘤放射治疗(RT)的年轻女性有发生卵巢早衰的风险。卵巢移位(OT)旨在保护这些患者的卵巢功能。然而,其在肛门直肠恶性肿瘤中的作用尚未得到明确确立。本综述的目的是确定腹腔镜 OT 在保留接受盆腔 RT 的肛门直肠恶性肿瘤的绝经前妇女卵巢功能方面的有效性。
系统检索 MEDLINE、Embase 和 CENTRAL,从建库至 2022 年 5 月。如果评估了接受盆腔 RT 的肛门直肠恶性肿瘤女性接受 OT 后卵巢功能的文章,则纳入研究。主要结局是卵巢功能保留。次要结局是 OT 后 30 天的术后发病率。
从 207 篇引文,纳入了 10 项研究,共 133 例接受 OT 前 RT 的直肠或肛门癌患者。卵巢功能保留的汇总比例的荟萃分析显示,保留卵巢功能的发生率为 66.9%(95% CI 55.0-79.0%,I²=43%)。30 天术后发病率为 1.2%(n=1)。干预措施和结局报告存在异质性。
对于接受盆腔放疗的肛门直肠恶性肿瘤的绝经前患者,腹腔镜 OT 可能是减少卵巢对 RT 暴露的有效技术。荟萃分析必须在纳入研究的临床异质性背景下进行解释。需要进一步的研究来充分调查 OT 在接受盆腔 RT 的肛门直肠恶性肿瘤患者中的结局。